血液造血干细胞移植中的输血支持:当代叙述审查
Brian D Adkins1, Jeremy W Jacobs2, Garrett S Booth3
1Pathology The University of Texas Southwestern Medical Center.
Clinical hematology international
|May 31, 2024
概括
造血干细胞移植 (HSCT) 需要谨慎的输血药物支持. 这包括在整个移植过程中管理细胞衰减和免疫接种.
科学领域:
- 血液学 血液学 血液学
- 输血医学 输血医学
背景情况:
- 造血干细胞移植 (HSCT) 是一个关键的医疗程序.
- 有效的HSCT严重依赖于强大的输血医学支持.
- 接受HSCT的患者经常经历与治疗相关的细胞衰减,改变血液产品的需求.
研究的目的:
- 为HSCT患者概述当前的输血实践.
- 突出输血医学在HSCT中的重要性.
- 讨论针对特定HSCT患者群体的管理策略.
主要方法:
- 对当代输血医学指导方针和实践的审查.
- 在移植前,移植期间和移植后阶段对血液产品需求的分析.
- 考虑挑战,如人类白细胞抗原 (HLA) 和红细胞 (RBC) 与免疫接种以及ABO不兼容的移植.
主要成果:
- HSCT患者有动态和多样化的血液产品需求.
- 艾洛免疫患者和ABO不兼容移植的管理需要专门的输血支持.
- 不断变化的输血指南和产品修改影响HSCT护理.
结论:
- 优化输血药物对于安全有效的HSCT至关重要.
- 移植团队和输血医学专业人员之间的密切合作至关重要.
- 遵守最新的指导方针可确保HSCT患者获得最佳结果.
相关概念视频
Regulation of Hematopoietic Stem Cells
3.2K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.2K
Bone Marrow Sampling and Transplants
324
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
324
Stem Cell Therapy for Tissue Regeneration
4.0K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.0K
Hematopoiesis
5.2K
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
5.2K
Tissue Transplantation
358
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
358
Multipotency of Hematopoietic Stem Cells
3.1K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.1K


